Wockhardt informs about press release

19 Sep 2024 Evaluate

Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed that it enclosed Press Release – ‘Wockhardt's Investigational Drug, Zaynich™ (Zidebactam/Cefepime) cures complex case of meningitis caused by pan-drug resistant super-bug under compassionate use’. A copy of the same will also be uploaded on the Company’s website www.wockhardt.com.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

1374.50 24.15 (1.79%)
22-Jan-2026 10:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1641.90
Dr. Reddys Lab 1215.45
Cipla 1380.65
Zydus Lifesciences 886.70
Lupin 2183.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×